Eiger BioPharmaceuticals Income from Continuous Operations 2012-2023 | EIGRQ
Eiger BioPharmaceuticals income from continuous operations from 2012 to 2023. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change